Biphasic/ Mixed
Mesothelioma are now becoming the most major type of mesothelioma. About 46-63%
cases of mesothelioma are now seen having biphasic type of tumor. This type of
tumor is basically is the combination of epithelial mesothelioma and
sarcomatoid mesothelioma. Furthermore, this tumor consists of two different
types and also the tumor is present in different parts. Eventually this makes a
lot easier to diagnose rather than the diagnosis of sarcomatoid and epithelial
mesothelioma. It doesn’t have a distinctive cell structure because it is
consists of two different cell types. To sum up briefly if a patient is
diagnosed with the biphasic/mixed tumor, basically it is diagnosed by both
tumors that are sarcomatoid and epithelial mesothelioma.
Treatment
The treatment options
for the biphasic mesothelioma are the same as epithelial mesothelioma and
sarcomatoid mesothelioma. The treatments can be used alone or can be in
combination of different options of treatment.
Mesothelioma treatment
can be divided into two wide categories. These comprise of traditional
mesothelioma treatment and new mesothelioma treatments.
Traditional
treatment includes radiation therapy, surgery and chemotherapy. In some cases
all the three approaches are applied to the patient keeping in mind his/her
condition and stage of cancer. This is done to achieve the very best results,
to live a quality and a better life and to increase survival rate. These
traditional treatments, I have already discussed in my previous post!
Now from my
viewpoint the most interesting way of treatment something very new!!!!!!
The new ways of
treatments include gene therapy, IMRT (Intensity Modulated Radiation Therapy),
immunotherapy, PDT (photodynamic therapy) and also advancements of new
chemotherapy agents. The great thing which I consider about these treatments
like immunotherapy, gene therapy and photodynamic therapy, gives us a lot hopes
to live a very healthy life! These treatments are used in combination with the
traditional ones but these are the major breakthrough in the field of medical
science.
No comments:
Post a Comment